> top > docs > PMC:3317373 > spans > 12232-12735 > annotations

PMC:3317373 / 12232-12735 JSONTXT

Annnotations TAB JSON ListView MergeView

2_test

Id Subject Object Predicate Lexical cue
22529521-16230799-67992086 162-163 16230799 denotes 2

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T5207 493-499 NN denotes Figure
T5206 492-493 -LRB- denotes (
T5205 490-491 -RRB- denotes )
T5204 486-490 CD denotes 0.01
T5203 484-485 SYM denotes <
T5202 482-483 NN denotes P
T5201 480-481 -COMMA- denotes ,
T5200 475-480 CD denotes 0.072
T5199 473-474 SYM denotes ±
T5198 468-472 CD denotes 2.28
T5197 461-467 IN denotes versus
T5196 455-460 CD denotes 0.173
T5195 453-454 SYM denotes ±
T5194 448-452 CD denotes 2.67
T5193 447-448 -LRB- denotes (
T5192 443-446 NN denotes TBI
T5191 440-442 NN denotes WT
T5190 434-439 NN denotes group
T5189 431-433 IN denotes in
T5188 426-430 IN denotes than
T5187 422-425 NN denotes TBI
T5186 419-421 NN denotes KO
T5185 413-418 NN denotes group
T5184 410-412 IN denotes in
T5183 401-409 VB denotes observed
T5182 397-400 VB denotes was
T5181 388-396 NN denotes activity
T5180 382-387 NN denotes NF-κB
T5179 375-381 JJ denotes higher
T5178 369-374 IN denotes while
T5177 367-368 -COMMA- denotes ,
T5176 358-367 NN denotes genotypes
T5175 353-357 DT denotes both
T5174 350-352 IN denotes of
T5173 339-349 NN denotes astrocytes
T5172 336-338 IN denotes in
T5171 330-335 NN denotes NF-κB
T5170 327-329 IN denotes of
T5169 316-326 NN denotes activation
T5168 308-315 VB denotes induced
T5167 301-307 NN denotes injury
T5166 293-300 NN denotes Scratch
T5165 285-291 NN denotes injury
T5164 277-284 NN denotes scratch
T5163 271-276 IN denotes after
T5162 269-270 NN denotes h
T5161 266-268 CD denotes 24
T5160 263-265 IN denotes at
T5159 258-262 NN denotes EMSA
T5158 255-257 IN denotes by
T5157 250-254 NN denotes mice
T5156 247-249 NN denotes KO
T5155 244-246 CC denotes or
T5154 241-243 NN denotes WT
T5153 236-240 NN denotes Nrf2
T5152 231-235 IN denotes from
T5151 220-230 NN denotes astrocytes
T5150 217-219 IN denotes of
T5149 211-216 NN denotes NF-κB
T5148 208-210 IN denotes of
T5147 199-207 NN denotes activity
T5146 187-198 JJ denotes DNA-binding
T5145 183-186 DT denotes the
T5144 175-182 VB denotes studied
T5143 172-174 PRP denotes we
T5142 170-171 -COMMA- denotes ,
T5141 166-170 RB denotes Here
T5140 163-164 -RRB- denotes ]
T5139 162-163 CD denotes 2
T5138 161-162 -LRB- denotes [
T5137 157-160 NNP denotes TBI
T5136 151-156 IN denotes after
T5135 145-150 NN denotes brain
T5134 142-144 IN denotes in
T5133 132-141 VB denotes activated
T5132 129-131 VB denotes is
T5131 123-128 NN denotes NF-κB
T5130 118-122 IN denotes that
T5129 109-117 VB denotes reported
T5128 104-108 VB denotes been
T5127 100-103 VB denotes has
T5126 97-99 PRP denotes It
T5125 90-96 NNP denotes Injury
T5124 82-89 NNP denotes Scratch
T5123 76-81 IN denotes after
T5122 67-75 NN denotes Activity
T5121 55-66 JJ denotes DNA-Binding
T5120 49-54 NN denotes NF-κB
T5119 46-48 IN denotes of
T5118 33-45 NN denotes Upregulation
T5117 24-32 VB denotes Enhanced
T5116 19-23 NN denotes Nrf2
T5115 16-18 IN denotes of
T5114 5-15 NN denotes Disruption
T5113 0-3 CD denotes 3.2
T5209 501-502 -RRB- denotes )
T5208 500-501 CD denotes 2
R4344 T5114 T5115 arg1Of Disruption,of
R4345 T5114 T5117 arg1Of Disruption,Enhanced
R4346 T5116 T5115 arg2Of Nrf2,of
R4347 T5117 T5123 arg1Of Enhanced,after
R4348 T5118 T5117 arg2Of Upregulation,Enhanced
R4349 T5118 T5119 arg1Of Upregulation,of
R4350 T5122 T5119 arg2Of Activity,of
R4351 T5122 T5120 arg1Of Activity,NF-κB
R4352 T5122 T5121 arg1Of Activity,DNA-Binding
R4353 T5125 T5123 arg2Of Injury,after
R4354 T5125 T5124 arg1Of Injury,Scratch
R4355 T5126 T5127 arg1Of It,has
R4356 T5126 T5128 arg1Of It,been
R4357 T5126 T5129 arg2Of It,reported
R4358 T5129 T5127 arg2Of reported,has
R4359 T5129 T5128 arg2Of reported,been
R4360 T5131 T5132 arg1Of NF-κB,is
R4361 T5131 T5133 arg2Of NF-κB,activated
R4362 T5133 T5129 arg3Of activated,reported
R4363 T5133 T5130 arg1Of activated,that
R4364 T5133 T5132 arg2Of activated,is
R4365 T5133 T5134 arg1Of activated,in
R4366 T5135 T5134 arg2Of brain,in
R4367 T5135 T5136 arg1Of brain,after
R4368 T5137 T5136 arg2Of TBI,after
R4369 T5137 T5138 arg1Of TBI,[
R4370 T5139 T5138 arg2Of 2,[
R4371 T5140 T5138 arg3Of ],[
R4372 T5143 T5144 arg1Of we,studied
R4373 T5144 T5141 arg1Of studied,Here
R4374 T5144 T5142 arg1Of studied,","
R4375 T5144 T5158 arg1Of studied,by
R4376 T5147 T5144 arg2Of activity,studied
R4377 T5147 T5145 arg1Of activity,the
R4378 T5147 T5146 arg1Of activity,DNA-binding
R4379 T5147 T5148 arg1Of activity,of
R4380 T5147 T5150 arg1Of activity,of
R4381 T5149 T5148 arg2Of NF-κB,of
R4382 T5151 T5150 arg2Of astrocytes,of
R4383 T5151 T5152 arg1Of astrocytes,from
R4384 T5154 T5153 arg1Of WT,Nrf2
R4385 T5154 T5155 arg1Of WT,or
R4386 T5155 T5152 arg2Of or,from
R4387 T5157 T5155 arg2Of mice,or
R4388 T5157 T5156 arg1Of mice,KO
R4389 T5159 T5158 arg2Of EMSA,by
R4390 T5159 T5160 arg1Of EMSA,at
R4391 T5162 T5160 arg2Of h,at
R4392 T5162 T5161 arg1Of h,24
R4393 T5162 T5163 arg1Of h,after
R4394 T5165 T5163 arg2Of injury,after
R4395 T5165 T5164 arg1Of injury,scratch
R4396 T5167 T5166 arg1Of injury,Scratch
R4397 T5167 T5168 arg1Of injury,induced
R4398 T5168 T5177 arg1Of induced,","
R4399 T5168 T5178 arg1Of induced,while
R4400 T5168 T5193 arg1Of induced,(
R4401 T5168 T5206 arg1Of induced,(
R4402 T5169 T5168 arg2Of activation,induced
R4403 T5169 T5170 arg1Of activation,of
R4404 T5169 T5172 arg1Of activation,in
R4405 T5171 T5170 arg2Of NF-κB,of
R4406 T5173 T5172 arg2Of astrocytes,in
R4407 T5173 T5174 arg1Of astrocytes,of
R4408 T5176 T5174 arg2Of genotypes,of
R4409 T5176 T5175 arg1Of genotypes,both
R4410 T5181 T5179 arg1Of activity,higher
R4411 T5181 T5180 arg1Of activity,NF-κB
R4412 T5181 T5182 arg1Of activity,was
R4413 T5181 T5183 arg2Of activity,observed
R4414 T5183 T5178 arg2Of observed,while
R4415 T5183 T5182 arg2Of observed,was
R4416 T5183 T5184 arg1Of observed,in
R4417 T5183 T5188 arg1Of observed,than
R4418 T5187 T5184 arg2Of TBI,in
R4419 T5187 T5185 arg1Of TBI,group
R4420 T5187 T5186 arg1Of TBI,KO
R4421 T5189 T5188 arg2Of in,than
R4422 T5192 T5189 arg2Of TBI,in
R4423 T5192 T5190 arg1Of TBI,group
R4424 T5192 T5191 arg1Of TBI,WT
R4425 T5196 T5197 arg1Of 0.173,versus
R4426 T5198 T5197 arg2Of 2.28,versus
R4427 T5198 T5199 arg1Of 2.28,±
R4428 T5200 T5193 arg2Of 0.072,(
R4429 T5200 T5194 arg1Of 0.072,2.67
R4430 T5200 T5195 arg1Of 0.072,±
R4431 T5200 T5196 arg1Of 0.072,0.173
R4432 T5200 T5201 arg1Of 0.072,","
R4433 T5202 T5201 arg2Of P,","
R4434 T5202 T5203 arg1Of P,<
R4435 T5202 T5204 arg1Of P,0.01
R4436 T5205 T5193 arg3Of ),(
R4437 T5207 T5206 arg2Of Figure,(
R4438 T5207 T5208 arg1Of Figure,2
R4439 T5209 T5206 arg3Of ),(

UBERON-AE

Id Subject Object Predicate Lexical cue
T5105 145-150 http://purl.obolibrary.org/obo/UBERON_0000955 denotes brain

GO-BP

Id Subject Object Predicate Lexical cue
T5112 316-335 http://purl.obolibrary.org/obo/GO_0051092 denotes activation of NF-κB
T5111 123-141 http://purl.obolibrary.org/obo/GO_0051092 denotes NF-κB is activated

GO-MF

Id Subject Object Predicate Lexical cue
T5214 191-198 http://purl.obolibrary.org/obo/GO_0005488 denotes binding
T5213 187-198 http://purl.obolibrary.org/obo/GO_0003677 denotes DNA-binding

sentences

Id Subject Object Predicate Lexical cue
T5110 293-503 Sentence denotes Scratch injury induced activation of NF-κB in astrocytes of both genotypes, while higher NF-κB activity was observed in group KO TBI than in group WT TBI (2.67 ± 0.173 versus 2.28 ± 0.072, P < 0.01) (Figure 2).
T5109 166-292 Sentence denotes Here, we studied the DNA-binding activity of NF-κB of astrocytes from Nrf2 WT or KO mice by EMSA at 24 h after scratch injury.
T5108 97-165 Sentence denotes It has been reported that NF-κB is activated in brain after TBI [2].
T5107 5-96 Sentence denotes Disruption of Nrf2 Enhanced Upregulation of NF-κB DNA-Binding Activity after Scratch Injury
T5106 0-4 Sentence denotes 3.2.
T130 0-4 Sentence denotes 3.2.
T131 5-96 Sentence denotes Disruption of Nrf2 Enhanced Upregulation of NF-κB DNA-Binding Activity after Scratch Injury
T132 97-165 Sentence denotes It has been reported that NF-κB is activated in brain after TBI [2].
T133 166-292 Sentence denotes Here, we studied the DNA-binding activity of NF-κB of astrocytes from Nrf2 WT or KO mice by EMSA at 24 h after scratch injury.
T134 293-503 Sentence denotes Scratch injury induced activation of NF-κB in astrocytes of both genotypes, while higher NF-κB activity was observed in group KO TBI than in group WT TBI (2.67 ± 0.173 versus 2.28 ± 0.072, P < 0.01) (Figure 2).

ICD10

Id Subject Object Predicate Lexical cue
T5212 301-307 http://purl.bioontology.org/ontology/ICD10/T14.9 denotes injury
T5211 285-291 http://purl.bioontology.org/ontology/ICD10/T14.9 denotes injury
T5210 90-96 http://purl.bioontology.org/ontology/ICD10/T14.9 denotes Injury

bionlp-st-ge-2016-test-ihmc

Id Subject Object Predicate Lexical cue
T5356 5-96 Positive_regulation denotes Disruption of Nrf2 Enhanced Upregulation of NF-κB DNA-Binding Activity after Scratch Injury
T5355 5-23 Negative_regulation denotes Disruption of Nrf2
T5354 118-164 Positive_regulation denotes that NF-κB is activated in brain after TBI [2]
T5353 118-128 Protein denotes that NF-κB
T5352 247-254 Protein denotes KO mice
T5351 208-216 Protein denotes of NF-κB
T5350 419-421 Protein denotes KO
T5349 236-243 Protein denotes Nrf2 WT
T5348 339-368 Entity denotes astrocytes of both genotypes,
T5347 16-23 Protein denotes of Nrf2
T5346 266-284 Entity denotes 24 h after scratch
T5345 327-335 Protein denotes of NF-κB
T5344 55-66 Entity denotes DNA-Binding
T5343 46-75 Protein denotes of NF-κB DNA-Binding Activity
T5342 220-254 Entity denotes astrocytes from Nrf2 WT or KO mice
T5341 382-387 Protein denotes NF-κB
T5340 247-249 Protein denotes KO
R4551 T5347 T5355 themeOf of Nrf2,Disruption of Nrf2
R4552 T5353 T5354 themeOf that NF-κB,that NF-κB is activated in brain after TBI [2]
R4553 T5355 T5356 causeOf Disruption of Nrf2,Disruption of Nrf2 Enhanced Upregulation of NF-κB DNA-Binding Activity after Scratch Injury

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T5327 502-503 . denotes .
T5326 501-502 -RRB- denotes )
T5325 500-501 CD denotes 2
T5324 493-499 NN denotes Figure
T5323 492-493 -LRB- denotes (
T5322 490-491 -RRB- denotes )
T5321 486-490 CD denotes 0.01
T5320 484-485 VBD denotes <
T5319 482-483 NNP denotes P
T5318 480-481 , denotes ,
T5317 475-480 CD denotes 0.072
T5316 473-474 CD denotes ±
T5315 468-472 CD denotes 2.28
T5314 461-467 IN denotes versus
T5313 455-460 CD denotes 0.173
T5312 453-454 CD denotes ±
T5311 448-452 CD denotes 2.67
T5310 447-448 -LRB- denotes (
T5309 443-446 NNP denotes TBI
T5308 440-442 NNP denotes WT
T5307 434-439 NN denotes group
T5306 431-433 IN denotes in
T5305 426-430 IN denotes than
T5304 422-425 NNP denotes TBI
T5303 419-421 NNP denotes KO
T5302 413-418 NN denotes group
T5301 410-412 IN denotes in
T5300 401-409 VBN denotes observed
T5299 397-400 VBD denotes was
T5298 388-396 NN denotes activity
T5297 382-387 NN denotes NF-κB
T5296 375-381 JJR denotes higher
T5295 369-374 IN denotes while
T5294 367-368 , denotes ,
T5293 358-367 NNS denotes genotypes
T5292 353-357 DT denotes both
T5291 350-352 IN denotes of
T5290 339-349 NNS denotes astrocytes
T5289 336-338 IN denotes in
T5288 330-335 NN denotes NF-κB
T5287 327-329 IN denotes of
T5286 316-326 NN denotes activation
T5285 308-315 VBD denotes induced
T5284 301-307 NN denotes injury
T5283 293-300 NN denotes Scratch
T5282 291-292 . denotes .
T5281 285-291 NN denotes injury
T5280 277-284 NN denotes scratch
T5279 271-276 IN denotes after
T5278 269-270 NN denotes h
T5277 266-268 CD denotes 24
T5276 263-265 IN denotes at
T5275 258-262 NNP denotes EMSA
T5274 255-257 IN denotes by
T5273 250-254 NNS denotes mice
T5272 247-249 NNP denotes KO
T5271 244-246 CC denotes or
T5270 241-243 NNP denotes WT
T5269 236-240 NNP denotes Nrf2
T5268 231-235 IN denotes from
T5267 220-230 NNS denotes astrocytes
T5266 217-219 IN denotes of
T5265 211-216 NN denotes NF-κB
T5264 208-210 IN denotes of
T5263 199-207 NN denotes activity
T5262 187-198 JJ denotes DNA-binding
T5261 183-186 DT denotes the
T5260 175-182 VBD denotes studied
T5259 172-174 PRP denotes we
T5258 170-171 , denotes ,
T5257 166-170 RB denotes Here
T5256 164-165 . denotes .
T5255 163-164 NNP denotes ]
T5254 162-163 CD denotes 2
T5253 161-162 NNP denotes [
T5252 157-160 NNP denotes TBI
T5251 151-156 IN denotes after
T5250 145-150 NN denotes brain
T5249 142-144 IN denotes in
T5248 132-141 VBN denotes activated
T5247 129-131 VBZ denotes is
T5246 123-128 NNP denotes NF-κB
T5245 118-122 IN denotes that
T5244 109-117 VBN denotes reported
T5243 104-108 VBN denotes been
T5242 100-103 VBZ denotes has
T5241 97-99 PRP denotes It
T5240 90-96 NNP denotes Injury
T5239 82-89 NNP denotes Scratch
T5238 76-81 IN denotes after
T5237 67-75 NN denotes Activity
T5236 55-66 NNP denotes DNA-Binding
T5235 49-54 NNP denotes NF-κB
T5234 46-48 IN denotes of
T5233 33-45 NNP denotes Upregulation
T5232 24-32 NNP denotes Enhanced
T5231 19-23 NNP denotes Nrf2
T5230 16-18 IN denotes of
T5229 5-15 NN denotes Disruption
T5228 3-4 . denotes .
T5227 0-3 CD denotes 3.2
R4452 T5234 T5233 prep of,Upregulation
R4453 T5235 T5236 compound NF-κB,DNA-Binding
R4454 T5236 T5234 pobj DNA-Binding,of
R4455 T5237 T5229 conj Activity,Disruption
R4456 T5238 T5229 prep after,Disruption
R4457 T5239 T5240 compound Scratch,Injury
R4458 T5240 T5238 pobj Injury,after
R4459 T5241 T5244 nsubjpass It,reported
R4460 T5242 T5244 aux has,reported
R4461 T5243 T5244 auxpass been,reported
R4462 T5244 T5244 ROOT reported,reported
R4463 T5245 T5248 mark that,activated
R4464 T5246 T5248 nsubjpass NF-κB,activated
R4465 T5247 T5248 auxpass is,activated
R4466 T5248 T5244 ccomp activated,reported
R4467 T5249 T5248 prep in,activated
R4468 T5250 T5249 pobj brain,in
R4469 T5251 T5248 prep after,activated
R4470 T5252 T5255 nmod TBI,]
R4471 T5253 T5255 nmod [,]
R4472 T5254 T5255 nummod 2,]
R4473 T5255 T5251 pobj ],after
R4474 T5256 T5244 punct .,reported
R4475 T5257 T5260 advmod Here,studied
R4476 T5258 T5260 punct ",",studied
R4477 T5259 T5260 nsubj we,studied
R4478 T5260 T5260 ROOT studied,studied
R4479 T5261 T5263 det the,activity
R4480 T5262 T5263 amod DNA-binding,activity
R4481 T5263 T5260 dobj activity,studied
R4482 T5264 T5263 prep of,activity
R4483 T5265 T5264 pobj NF-κB,of
R4484 T5266 T5265 prep of,NF-κB
R4485 T5267 T5266 pobj astrocytes,of
R4486 T5268 T5265 prep from,NF-κB
R4487 T5269 T5270 compound Nrf2,WT
R4488 T5270 T5268 pobj WT,from
R4489 T5271 T5270 cc or,WT
R4490 T5272 T5270 conj KO,WT
R4491 T5273 T5264 pobj mice,of
R4492 T5274 T5260 prep by,studied
R4493 T5275 T5274 pobj EMSA,by
R4494 T5276 T5260 prep at,studied
R4495 T5277 T5278 nummod 24,h
R4496 T5278 T5276 pobj h,at
R4497 T5279 T5260 prep after,studied
R4498 T5280 T5281 compound scratch,injury
R4499 T5281 T5279 pobj injury,after
R4500 T5282 T5260 punct .,studied
R4501 T5283 T5285 advmod Scratch,induced
R4502 T5284 T5285 nsubj injury,induced
R4503 T5285 T5285 ROOT induced,induced
R4504 T5286 T5285 dobj activation,induced
R4505 T5287 T5286 prep of,activation
R4506 T5288 T5287 pobj NF-κB,of
R4507 T5289 T5286 prep in,activation
R4508 T5290 T5289 pobj astrocytes,in
R4509 T5291 T5290 prep of,astrocytes
R4510 T5292 T5293 det both,genotypes
R4511 T5293 T5291 pobj genotypes,of
R4512 T5294 T5285 punct ",",induced
R4513 T5295 T5300 mark while,observed
R4514 T5296 T5298 amod higher,activity
R4515 T5297 T5298 compound NF-κB,activity
R4516 T5298 T5300 nsubjpass activity,observed
R4517 T5299 T5300 auxpass was,observed
R4518 T5300 T5285 advcl observed,induced
R4519 T5301 T5300 prep in,observed
R4520 T5302 T5304 compound group,TBI
R4521 T5303 T5304 compound KO,TBI
R4522 T5304 T5301 pobj TBI,in
R4523 T5305 T5300 prep than,observed
R4524 T5306 T5305 prep in,than
R4525 T5307 T5309 compound group,TBI
R4526 T5308 T5309 compound WT,TBI
R4527 T5309 T5306 pobj TBI,in
R4528 T5310 T5309 punct (,TBI
R4529 T5311 T5312 nummod 2.67,±
R4530 T5312 T5320 dep ±,<
R4531 T5313 T5320 dep 0.173,<
R4532 T5314 T5320 prep versus,<
R4533 T5315 T5316 nummod 2.28,±
R4534 T5316 T5314 pobj ±,versus
R4535 T5317 T5316 appos 0.072,±
R4536 T5318 T5320 punct ",",<
R4537 T5319 T5320 nsubj P,<
R4538 T5320 T5320 ROOT <,<
R4539 T5321 T5320 npadvmod 0.01,<
R4540 T5322 T5320 punct ),<
R4541 T5323 T5324 punct (,Figure
R4542 T5324 T5320 appos Figure,<
R4543 T5325 T5324 nummod 2,Figure
R4544 T5326 T5324 punct ),Figure
R4545 T5327 T5320 punct .,<
R4445 T5227 T5227 ROOT 3.2,3.2
R4446 T5228 T5227 punct .,3.2
R4447 T5229 T5244 nsubj Disruption,reported
R4448 T5230 T5229 prep of,Disruption
R4449 T5231 T5233 compound Nrf2,Upregulation
R4450 T5232 T5233 compound Enhanced,Upregulation
R4451 T5233 T5230 pobj Upregulation,of

bionlp-st-ge-2016-test-tees

Id Subject Object Predicate Lexical cue
T5226 308-315 Positive_regulation denotes induced
T5225 316-326 Positive_regulation denotes activation
T5224 382-387 Protein denotes NF-κB
T5223 330-335 Protein denotes NF-κB
T5222 236-243 Protein denotes Nrf2 WT
T5221 211-216 Protein denotes NF-κB
T5220 132-141 Positive_regulation denotes activated
T5219 123-128 Protein denotes NF-κB
T5218 24-32 Positive_regulation denotes Enhanced
T5217 33-45 Positive_regulation denotes Upregulation
T5216 49-54 Protein denotes NF-κB
T5215 19-23 Protein denotes Nrf2
R4442 T5219 T5220 themeOf NF-κB,activated
R4443 T5223 T5225 themeOf NF-κB,activation
R4444 T5225 T5226 themeOf activation,induced
R4440 T5216 T5217 themeOf NF-κB,Upregulation
R4441 T5217 T5218 themeOf Upregulation,Enhanced

testone

Id Subject Object Predicate Lexical cue
T5104 33-45 Positive_regulation denotes Upregulation
T5103 24-32 Positive_regulation denotes Enhanced
T5102 5-15 Negative_regulation denotes Disruption
R4343 T5104 T5103 themeOf Upregulation,Enhanced